Inari Medical Inc [NARI] stock is trading at $79.29, down -0.01%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NARI shares have gain 53.07% over the last week, with a monthly amount glided 48.51%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Inari Medical Inc [NASDAQ: NARI] stock has seen the most recent analyst activity on December 17, 2024, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $75. Previously, Stifel started tracking the stock with Hold rating on September 18, 2024, and set its price target to $50. On September 03, 2024, Leerink Partners initiated with a Market Perform rating and assigned a price target of $47 on the stock. Deutsche Bank started tracking the stock assigning a Buy rating and suggested a price target of $68 on August 09, 2024. William Blair initiated its recommendation with a Outperform. Needham downgraded its rating to Hold for this stock on July 18, 2024. In a note dated February 29, 2024, Piper Sandler downgraded an Neutral rating on this stock and revised its target price from $85 to $55.
Inari Medical Inc [NARI] stock has fluctuated between $36.73 and $79.69 over the past year. Currently, Wall Street analysts expect the stock to reach $65.63 within the next 12 months. Inari Medical Inc [NASDAQ: NARI] shares were valued at $79.29 at the most recent close of the market. An investor can expect a potential drop of -17.23% based on the average NARI price forecast.
Analyzing the NARI fundamentals
Inari Medical Inc [NASDAQ:NARI] reported sales of 574.50M for the trailing twelve months, which represents a growth of 21.39%. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at -0.08%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.18 and Total Capital is -0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 79.15 points at the first support level, and at 79.02 for the second support level. However, for the 1st resistance point, the stock is sitting at 79.43, and for the 2nd resistance point, it is at 79.58.
Ratios To Look Out For
For context, Inari Medical Inc’s Current Ratio is 1.77. In addition, the Quick Ratio stands at 1.40 and the Cash Ratio stands at 0.28. Considering the valuation of this stock, the price to sales ratio is 8.08, the price to book ratio is 10.66.
Transactions by insiders
Recent insider trading involved Hoffman William, Director, that happened on Jan 06 ’25 when 0.2 million shares were sold. Director, WILLIAM HOFFMAN completed a deal on Jan 06 ’25 to buy 0.2 million shares. Meanwhile, President and CEO Hykes Andrew sold 3000.0 shares on Dec 20 ’24.
